Grace Therapeutics, Inc. (GRCE) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by Grace Therapeutics, Inc. on September 12, 2025. The Company is incorporated in Delaware and its common stock trades on The Nasdaq Stock Market LLC under the symbol "GRCE". The record date for the meeting was July 18, 2025.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results rather than financial performance.
Material Changes and Voting Results
Stockholders representing 57.32% of the 13,828,562 shares issued and outstanding (7,926,945 shares) were present or represented by proxy. Three proposals were acted upon:
- Proposal 1 (Election of Directors): All five nominees were elected. Broker non-votes totaled 1,598,490 for each nominee.
- Vimal Kavuru: 6,294,270 For, 34,185 Withheld
- A. Brian Davis: 6,299,935 For, 28,520 Withheld
- Prashant Kohli: 6,299,420 For, 29,035 Withheld
- S. George Kottayil: 6,300,168 For, 28,287 Withheld
- Edward Neugeboren: 6,300,263 For, 28,192 Withheld
- Proposal 2 (Advisory Vote on Executive Compensation): Approved.
- For: 6,178,757
- Against: 74,002
- Abstain: 75,696
- Broker Non-Votes: 1,598,490
- Proposal 3 (Ratification of Auditors): KPMG LLP was ratified as the independent registered public accounting firm for the fiscal year ending March 31, 2026.
- For: 7,797,832
- Against: 127,248
- Abstain: 1,865
- Broker Non-Votes: 0
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document serves strictly as a record of the voting outcomes.
Key Facts for Investor Verification
- Verify the total number of shares outstanding (13,828,562) and the percentage of shares represented at the meeting (57.32%).
- Confirm the re-election of the current board of directors, noting the specific vote counts for each nominee.
- Review the significant number of broker non-votes (1,598,490) on the director election and executive compensation proposals, which indicates shares held in street name where brokers lacked discretionary voting power.
- Confirm the ratification of KPMG LLP as the auditor for the fiscal year ending March 31, 2026.